Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2026-02-24 @ 2:30 PM
Study NCT ID:
NCT00446134
Status:
COMPLETED
Last Update Posted:
2012-07-27
First Post:
2007-03-08
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)
Sponsor:
Bausch Health Americas, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
RNA003142-204
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None